Adipokines vaspin and omentin-1 are up-regulated in large for gestational age infants at term

Cytokine

Volumn 62, Issue 1, 2013, Pages 70-74

  Kafalidis, George ^a   Boutsikou, Theodora ^a   Briana, Despina D ^a   Boutsikou, Maria ^a   Marmarinos, Antonios ^a   Baka, Stavroula ^a   Hassiakos, Demetrios ^a   Gourgiotis, Demetrios ^a   Malamitsi Puchner, Ariadne ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Adipokines; Fetus; Neonate; Omentin 1; Vaspin

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; INSULIN; OMENTIN 1; UNCLASSIFIED DRUG; VASPIN;

ADULT; ARTICLE; CONTROLLED STUDY; FAT MASS; FEMALE; FETUS; HUMAN; INFANT; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LARGE FOR GESTATIONAL AGE; MALE; MATERNAL DIABETES MELLITUS; METABOLIC SYNDROME X; NEWBORN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; UMBILICAL CORD BLOOD; UPREGULATION; VAGINAL DELIVERY;

BIRTH WEIGHT; CYTOKINES; DEMOGRAPHY; FETAL BLOOD; GESTATIONAL AGE; GPI-LINKED PROTEINS; HUMANS; INFANT, NEWBORN; INSULIN; LECTINS; SERPINS; TERM BIRTH; UP-REGULATION;

EID: 84875805564     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.02.016     Document Type: Article

References (36)

1. Barker D.J. The fetal origins of coronary heart disease. Acta Paediatr. Suppl. 1997, 422:78-82.
2. Boney C.M., Verma A., Tucker R., Vohr B.R. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005, 115:290-296.
3. Krew M.A., Kehl R.J., Thomas A., Catalano P. Relation of amniotic fluid C-peptide levels to neonatal body composition. Am. J. Obstet. Gynecol. 1994, 84:96-100.
4. Pittas A.G., Joseph N.A., Greenberg A.S. Adipocytokines and insulin resistance. J. Clin. Endocrinol. Metab. 2004, 89:447-452.
5. Deng Y., Scherer P.E. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann. N.Y. Acad. Sci. 2010, 1212:E1-E19.
6. Hida K., Wada J., Eguchi J., Zhang H., Baba M., Seida A., et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc. Natl. Acad. Sci. USA 2005, 102:10610-10615.
7. Yang R.Z., Lee M.J., Hu H., Pray J., Wu H.B., Hansen B.C., et al. Identification of omentin as a novel depot specific adipokine in human adipose tissue: possible role in modulating insulin action. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E1253-E1261.
8. Tsuji S., Uehori J., Matsumoto M., Suzuki Y., Matsuhisa A., Toyoshima K., et al. Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J. Biol. Chem. 2001, 276:23456-23463.
9. de Souza Batista C.M., Yang R.Z., Lee M.J., Glynn N.M., Yu D.Z., Pray J., et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007, 56:1655-1661.
10. Pan H.Y., Guo L., Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res. Clin. Pract. 2010, 88:29-33.
11. Gardosi J., Chang A., Kaylan B., Sahota D., Symonds E.M. Customised antenatal growth charts. Lancet 1992, 339:283-287.
12. Gardosi J., Mongelli M., Wilcox M., Chang A. An adjustable fetal weight standard. Ultrasound Obstet. Gynecol. 1995, 6:168-174.
13. Arioglu E., Rother K.I., Reitman M.L., Premkumar A., Taylor S.I. Lipoatrophy syndromes: when 'too little fat' is a clinical problem. Pediatr. Diabetes. 2000, 1:155-168.
14. Oral E.A., Simha V., Ruiz E., Andewelt A., Premkumar A., Snell P., et al. Leptin-replacement therapy for lipodystrophy. N. Engl. J. Med. 2002, 346:570-578.
15. Vitoratos N., Deliveliotou A., Vlahos N.F., Mastorakos G., Papadias K., Botsis D., et al. Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls. Gynecol. Endocrinol. 2008, 24:614-619.
16. Hediger M., Overpeck M., Mcglynn A., Kuczmarski R., Maurer K., Davis W. Growth and fatness at three to six years of age of children born small- or large-for-gestational age pediatrics. 1999, 104:33-39.
17. Nold J., Georgieff M. Infants of diabetic mothers. Pediatr. Clin. North Am. 2004, 51:619-637.
18. Das U., Sysyn G. Abnormal fetal growth: intrauterine growth retardation, small for gestational age, large for gestational age. Pediatr. Clin. North Am. 2004, 51:639-654.
19. Langer O. Fetal macrosomia: etiologic factors. Clin. Obstet. Gynecol. 2000, 43:283-297.
20. Catalano P., Kirwan J., Haugel-de Mouzon S., King J. Gestational diabetes and insulin resistance: role in short- and longterm implications for mother and fetus. J. Nutr. 2003, 133:1674-1683.
21. Klöting N., Berndt J., Kralisch S., Kovacs P., Fasshauer M., Schön M.R., et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem. Biophys. Res. Commun. 2006, 339:430-436.
22. Zvonic S., Lefevre M., Kilroy G., Floyd Z.E., DeLany J.P., Kheterpal I., et al. Secretome of primary cultures of human adipose-derived stem cells. Mol. Cell. Proteomics 2007, 6:18-28.
23. Youn B., Kloting N., Kratzsch J., Lee N., Park J.W., Song E., et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008, 57:372-377.
24. Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin. Investig. Drugs 2008, 17:327-333.
25. Seeger J., Ziegelmeier M., Bachmann A., Lossner U., Kratzsch J., Bluher M., et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J. Clin Endocrinol. Metab. 2008, 93:247-251.
26. von Loeffelholz C., Möhlig M., Arafat A.M., Isken F., Spranger J., Mai K., et al. Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. Eur. J. Endocrinol. 2010, 162:507-513.
27. Briana D.D., Boutsikou M., Baka S., Gourgiotis D., Marmarinos A., Liosi S., et al. Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies. Metab. Clin. Exp. 2011, 60:486-490.
28. Giomisi A., Kourtis A., Toulis K.A., Anastasilakis A.D., Makedou K.G., Mouzaki M., et al. Serum vaspin levels in normal pregnancy in comparison with non-pregnant women. Eur. J. Endocrinol. 2011, 164:579-583.
29. Klöting N., Kovacs P., Kern M., Heiker J.T., Fasshauer M., Schön M.R., et al. Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia 2011, 54:1819-1823.
30. Tan B.K., Heutling D., Chen J., Farhatullah S., Adya R., Keay S.D., et al. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 2008, 57:1501-1507.
31. Evagelidou E.N., Kiortsis D.N., Bairaktari E.T., Giapros V.I., Cholevas V.K., Tzallas C.S., et al. Lipid profile, glucose homeostasis, blood pressure, and obesity-anthropometric markers in macrosomic offspring of nondiabetic mothers. Diabetes Care 2006, 29:1197-1201.
32. Cai R.C., Wei L., Di J.Z., Yu H.Y., Bao Y.Q., Jia W.P. Expression of omentin in adipose tissues in obese and type 2 diabetic patients. Zhonghua. Yi. Xue. Za. Zhi. 2009, 89:381-384.
33. Tan B.K., Adya R., Farhatullah S., Lewandowski K.C., O'Hare P., Lehnert H., et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes 2008, 57:801-808.
34. Schaffler A., Neumeier M., Herfarth H., Furst A., Scholmerich J., Buchler C. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim. Biophys. Acta. 2005, 1732:96-102.
35. Tan B.K., Adya R., Randeva H.S. Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc. Med. 2010, 20:143-148.
36. Malamitsi-Puchner A., Protonotariou E., Boutsikou T., Makrakis E., Sarandakou A., Creatsas G. The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period. Early Hum. Dev. 2005, 81:387-392.